Skip to main content
Top
Published in: Clinical Rheumatology 6/2017

01-06-2017 | Brief Report

DASH diet and change in serum uric acid over time

Authors: Olive Tang, Edgar R. Miller III, Allan C. Gelber, Hyon K. Choi, Lawrence J. Appel, Stephen P. Juraschek

Published in: Clinical Rheumatology | Issue 6/2017

Login to get access

Abstract

The Dietary Approaches to Stop Hypertension (DASH) diet lowers serum uric acid (SUA) levels compared to the typical American (control) diet. However, the time required for the DASH diet to take effect is unknown. We analyzed data from a parallel arm, randomized-controlled trial in pre-hypertensive or hypertensive adults (N = 103), comparing the effects of DASH or a control diet on SUA measured at 30, 60, and 90 days. Effects were examined overall and within stratified subgroups based on baseline SUA status (SUA ≥6 mg/dL vs <6 mg/dL). The mean age of participants was 51.5 ± 9.7 years, 55% were women, 75% were black, 42% were obese, and 34% had hypertension. Twenty-four of the 103 (23%) participants had a baseline SUA ≥6 mg/dL. Overall, compared to the control, DASH lowered SUA by 0.5 mg/dL at 30 and 90 days. Among participants with baseline SUA ≥6 mg/dL, DASH lowered SUA by 0.8 and 1.0 mg/dL at 30 and 90 days, respectively. These findings demonstrate that the DASH diet reduces SUA within 30 days, with a sustained effect at 90 days, which is informative for healthcare providers counseling patients on time course expectations for uric acid reduction in response to dietary modification.
Appendix
Available only for authorised users
Literature
1.
go back to reference Juraschek SP, Kovell LC, Miller ER III, Gelber AC (2015) Gout, Urate lowering therapy and uric acid levels among US adults. Arthritis Care Res 67:588–592. doi:10.1002/acr.22469 CrossRef Juraschek SP, Kovell LC, Miller ER III, Gelber AC (2015) Gout, Urate lowering therapy and uric acid levels among US adults. Arthritis Care Res 67:588–592. doi:10.​1002/​acr.​22469 CrossRef
3.
go back to reference Choi HK, Atkinson K, Karlson E et al (2004) Purine-rich foods, dairy and protein intake, and the risk of gout in men. NEJM 350:1093–1103CrossRefPubMed Choi HK, Atkinson K, Karlson E et al (2004) Purine-rich foods, dairy and protein intake, and the risk of gout in men. NEJM 350:1093–1103CrossRefPubMed
4.
go back to reference Choi HK, Liu S, Curhan G (2005) Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the third national health and nutrition examination survey. Arthritis Rheum 52:283–289. doi:10.1002/art.20761 CrossRefPubMed Choi HK, Liu S, Curhan G (2005) Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the third national health and nutrition examination survey. Arthritis Rheum 52:283–289. doi:10.​1002/​art.​20761 CrossRefPubMed
5.
go back to reference Huang H-Y, Appel LJ, Choi MJ et al (2005) The effects of vitamin C supplementation on serum concentrations of uric acid: results of a randomized controlled trial. Arthritis Rheum 52:1843–1847. doi:10.1002/art.21105 CrossRefPubMed Huang H-Y, Appel LJ, Choi MJ et al (2005) The effects of vitamin C supplementation on serum concentrations of uric acid: results of a randomized controlled trial. Arthritis Rheum 52:1843–1847. doi:10.​1002/​art.​21105 CrossRefPubMed
6.
8.
go back to reference Juraschek SP, Gelber AC, Choi HK et al (2016) Effects of the dietary approaches to Stop hypertension (DASH) diet and sodium intake on serum uric acid. Arthritis Rheumatol. doi:10.1002/art.39813 Juraschek SP, Gelber AC, Choi HK et al (2016) Effects of the dietary approaches to Stop hypertension (DASH) diet and sodium intake on serum uric acid. Arthritis Rheumatol. doi:10.​1002/​art.​39813
10.
11.
go back to reference Sacks F, Svetkey L, Vollmer W et al (2001) Effects on blood pressure of reduced dietary sodium and the dietary approaches to Stop hypertension (DASH) diet. N Engl J Med 344:3–10CrossRefPubMed Sacks F, Svetkey L, Vollmer W et al (2001) Effects on blood pressure of reduced dietary sodium and the dietary approaches to Stop hypertension (DASH) diet. N Engl J Med 344:3–10CrossRefPubMed
12.
go back to reference Khanna D, Fitzgerald JD, Khanna PP et al (2012) 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken) 64:1431–1446. doi:10.1002/acr.21772 CrossRef Khanna D, Fitzgerald JD, Khanna PP et al (2012) 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken) 64:1431–1446. doi:10.​1002/​acr.​21772 CrossRef
13.
go back to reference Juraschek SP, McAdams-Demarco M, Gelber AC et al (2016) Effects of lowering glycemic index of dietary carbohydrate on plasma uric acid levels: the OmniCarb randomized clinical trial. Arthritis Rheumatol 68:1281–1289. doi:10.1002/art.39527 CrossRefPubMed Juraschek SP, McAdams-Demarco M, Gelber AC et al (2016) Effects of lowering glycemic index of dietary carbohydrate on plasma uric acid levels: the OmniCarb randomized clinical trial. Arthritis Rheumatol 68:1281–1289. doi:10.​1002/​art.​39527 CrossRefPubMed
14.
15.
go back to reference Dalbeth N, Ames R, Gamble GD et al (2012) Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomised controlled trial. Ann Rheum Dis 71:929–934. doi:10.1136/annrheumdis-2011-200156 CrossRefPubMed Dalbeth N, Ames R, Gamble GD et al (2012) Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomised controlled trial. Ann Rheum Dis 71:929–934. doi:10.​1136/​annrheumdis-2011-200156 CrossRefPubMed
Metadata
Title
DASH diet and change in serum uric acid over time
Authors
Olive Tang
Edgar R. Miller III
Allan C. Gelber
Hyon K. Choi
Lawrence J. Appel
Stephen P. Juraschek
Publication date
01-06-2017
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 6/2017
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-017-3613-x

Other articles of this Issue 6/2017

Clinical Rheumatology 6/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.